Abstract
The accuracy of disk susceptibility tests with ampicillin and ampicillin-sulbactam was not improved when the amount of ampicillin was increased from 10 to 20 or 30 micrograms per disk. For testing members of the family Enterobacteriaceae, ampicillin disk tests correlated better with broth microdilution tests when the zone size standards were altered from greater than or equal to 14 greater than or equal to 17 mm for susceptible and from less than or equal to 11 to less than or equal to 13 mm for resistant. The same zone size breakpoints apply to tests with ampicillin-sulbactam disks (10/10 micrograms). When Staphylococcus, Branhamella, and Haemophilus species are tested against ampicillin, interpretive breakpoints are those separating beta-lactamase-producing strains from nonproducing strains. However, when ampicillin-sulbactam is tested, beta-lactamase enzymes are efficiently inhibited by the sulbactam component, and thus zone size standards for ampicillin do not apply: zone size standards for the Enterobacteriaceae can be used for testing the combination against Staphylococcus, Branhamella, and Haemophilus species. For Streptococcus, Enterococcus, and Listeria species, only ampicillin disks need be tested, since ampicillin-sulbactam disks give essentially identical results.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aswapokee N., Neu H. C. A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor. J Antibiot (Tokyo) 1978 Dec;31(12):1238–1244. doi: 10.7164/antibiotics.31.1238. [DOI] [PubMed] [Google Scholar]
- Barry A. L., Jones R. N., Thornsberry C. Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks. J Clin Microbiol. 1984 Feb;19(2):134–139. doi: 10.1128/jcm.19.2.134-139.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown R. M., Wise R., Andrews J. M., Hancox J. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration. Antimicrob Agents Chemother. 1982 Apr;21(4):565–567. doi: 10.1128/aac.21.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foulds G. Pharmacokinetics of sulbactam/ampicillin in humans: a review. Rev Infect Dis. 1986 Nov-Dec;8 (Suppl 5):S503–S511. doi: 10.1093/clinids/8.supplement_5.503. [DOI] [PubMed] [Google Scholar]
- Jones R. N., Barry A. L. Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination. J Clin Microbiol. 1987 Oct;25(10):1920–1925. doi: 10.1128/jcm.25.10.1920-1925.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luman I., Wilson R. W., Wallace R. J., Jr, Nash D. R. Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production. Antimicrob Agents Chemother. 1986 Nov;30(5):774–776. doi: 10.1128/aac.30.5.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oberhofer T. R., Towle D. W. Evaluation of the rapid penicillinase paper strip test for detection of beta-lactamase. J Clin Microbiol. 1982 Feb;15(2):196–199. doi: 10.1128/jcm.15.2.196-199.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Retsema J. A., English A. R., Girard A. E. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides. Antimicrob Agents Chemother. 1980 Apr;17(4):615–622. doi: 10.1128/aac.17.4.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sherris J. C., Rashad A. L., Lighthart G. A. Laboratory determination of antibiotic susceptibility to ampicillin and cephalothin. Ann N Y Acad Sci. 1967 Sep 27;145(2):248–267. doi: 10.1111/j.1749-6632.1967.tb50223.x. [DOI] [PubMed] [Google Scholar]
- Washburn R. G., Durack D. T. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus. J Infect Dis. 1981 Sep;144(3):237–243. doi: 10.1093/infdis/144.3.237. [DOI] [PubMed] [Google Scholar]
- Wiggins G. L., Albritton W. L., Feeley J. C. Antibiotic susceptibility of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother. 1978 May;13(5):854–860. doi: 10.1128/aac.13.5.854. [DOI] [PMC free article] [PubMed] [Google Scholar]